Overview

Comparison of I.V. CTAP201 and Doxercalciferol (Hectorol) in Subjects With Chronic Kidney Disease (CKD) and Secondary Hyperparathyroidism (SHPT)

Status:
Completed

Trial end date:
2009-10-01

Target enrollment:

Participant gender:

Summary

This study will compare CTAP201 with Doxercalciferol in patients with chronic kidney disease (CKD) and secondary hyperparathyroidism (SHPT), undergoing regular hemodialysis, at different dose strengths. This study will also investigate the levels of CTAP201 in the body over time and determine the safety of CTAP201.

Phase:

Phase 1

Details

Lead Sponsor:

OPKO IP Holdings II, Inc.

Treatments:

1 alpha-hydroxyergocalciferol
Ergocalciferols